Rapidly progressive emphysema developed in a 59 year old smoker after exposure to cadmium fumes in a factory. Very high levels of cadmium in air sampled at the workplace and in the patient's blood, urine, and lung tissue confirmed massive exposure. These data strongly suggest an association between the patient's cadmium exposure and the development of emphysema. (Thorax 1993;48:570-571) Cadmium is a byproduct of the zinc and lead industry. It is mainly used for metal plating and for the production of batteries, pigments, plastic stabilisers, and some alloys. Chronic inhalation of cadmium fumes and dusts has been associated with emphysema.'15 Other markers of chronic cadmium intoxication are renal failure, proteinuria and, in the advanced stage, osteomalacia.6 We report the case of a patient who was exposed to very high levels of cadmium and who presented with rapidly progressive emphysema.
Case report A 59 year old man had smoked a mean of 20 cigarettes daily since the age of 16. He had no past history of respiratory disease. In 1975 he became a furnace worker in a plant producing cadmium salts and oxides. No chest radiograph was taken at that time. During the following four years he was exposed to a very dusty environment and almost every day handled, without protection, cadmium pieces coming out from the furnaces.
In the course of a medical survey carried out in 1979, airborne cadmium levels were measured in the workplace and showed mean values of 446 pg/m3 (range 164-1192 ,g/m3 during day) equal to about nine times the current threshold limit value of 50 ,g/m3n. Air sampling was carried out with a personal air sampler equipped with a filter holder. After treatment with nitric acid the filter was analysed by flameless atomic absorption spectroscopy. The cumulative integrated exposure to cadmium was estimated at 1600 pg/m3 x years.
In 1979 clinical examination of the patient showed slight renal failure (serum creatinine, 1-6 mg/dl; normal, 0-95-1-2 mg/dl; creatinine clearance, 75 ml/min) and elevated cadmium levels in blood and urine (table) . Moderate proteinuria was also present (127 mg/100 ml) with#,2 microglobulinuria (2002 yll; normal <300 y/l). He had no respiratory symptoms but his chest radiograph and lung function tests were consistent with pulmonary emphysema (table) . The serum a,-antitrypsin level was normal (313 mg/dl) and his Pi phenotype was MM.
The patient was considered to have an occupational disease and was told to stop work. During the following 10 years, blood and urine cadmium levels, chest radiography, and lung function were regularly monitored. The patient first noticed exertional dyspnoea in 1983, and this was incapacitating by 1989.
Severe impairment of lung function (table) and radiographic appearance of emphysema ( fig 1) were present at that time. Chest radiography also disclosed a nodule in the right pulmonary field (fig 1) and a computed tomographic scan suggested a neoplasm. Repeated bronchoscopic procedures failed to confirm a diagnosis of lung cancer but, since there was no evidence of metastases nor disease of the mediastinal lymph nodes, the right middle lobe was removed. Histological examination of the tumour showed a poorly differentiated adenocarcinoma surrounded by advanced panacinar emphysema and considerable dilatations of centrilobular structures (fig 2) . There was no interstitial fibrosis.
The mean concentration of cadmium in the lung parenchyma was 580 ,ug/g dry tissue compared with a mean of 14 ug/g in three unexposed controls matched for age, sex, and smoking habits who had also undergone resection of a bronchial carcinoma.
Discussion
Since Friberg first suggested a relationship between cadmium exposure and emphysema The evidence suggests that cadmium was responsible, in part at least, for the development of emphysema in our patient. The patient also had proteinuria and renal impairment, other common signs of chronic cadmium intoxication. The evolution of emphysema was exceptionally fast; the mean annual loss of FEV1 was 140 ml which is unusual for emphysema in a smoker (A FEV, = 80-120 ml/year) in the absence of a,-antitrypsin deficiency.9 The exposure to cadmium appears to have been very high as judged by cadmium levels in lung parenchyma, blood, urine, and at the workplace of the patient. The very high lung cadmium concentrations (580 ,ug/g dry tissue compared with the usual values in human lung tissue 0 64-1 48 ,ug/g dry tissue)'0 were consistent with a very high cumulative exposure. During the 10 years of follow up the blood and urine concentrations of cadmium progressively decreased. The cadmium concentration in the lung in 1989, however, was 150 times the values observed in control cases. Blood concentrations probably mainly reflect the average intake of cadmium during recent months whereas lung concentrations provide a direct assessment of the cadmium lung burden which is probably of more relevance for cadmium lung toxicity.
Our patient was also a smoker and tobacco might have had a synergistic effect, either by increasing the cadmium burden on the lung since cadmium is a constituent of tobacco, or indirectly by reducing lung clearance of cadmium.'0 As far as we are aware this is the first time 
